speb/financial-data huggingface dataset:
DuPont ROE decomposition for CSMG3.SA (annual period ending 2024-12-31)
ROE: 14.881292875759177%
Net margin: 16.716412757238317%
Asset turnover: 0.46902813944929495
Equity multiplier (leverage): 1.898010798015954
EBIT margin: 27.658153598765985%
Interest burden factor: 0.7678175014950128
Tax burden factor: 0.7871579659606721
ROE archetype: Standard Business
DuPont ROE decomposition for CSMG3.SA (annual period ending 2025-12-31)
ROE: 18.017832389675366%
Net margin: 16.99533864173566%
Asset turnover: 0.5290346848595865
Equity multiplier (leverage): 2.003957808428026
EBIT margin: 26.406096379554366%
Interest burden factor: 0.7951822948631573
Tax burden factor: 0.8093920172427099
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CSR (quarterly period ending 2025-03-31)
ROE: -0.40613636363636363%
Net margin: -5.326934255436484%
Asset turnover: 0.035441110906858864
Equity multiplier (leverage): 2.151231818181818
EBIT margin: 7.8666925014532065%
Interest burden factor: -0.7921561197423267
ROE archetype: Low Return
DuPont ROE decomposition for CSR (quarterly period ending 2025-06-30)
ROE: -1.6644520352578598%
Net margin: -20.94122452552189%
Asset turnover: 0.03509643211787658
Equity multiplier (leverage): 2.2646768609281045
EBIT margin: 11.883470218383929%
Interest burden factor: -2.0605205008593175
ROE archetype: Low Return
DuPont ROE decomposition for CSR (quarterly period ending 2025-09-30)
ROE: 7.553689306485216%
Net margin: 91.60912617823779%
Asset turnover: 0.034736897158613375
Equity multiplier (leverage): 2.3737192634783373
EBIT margin: 9.078558523228617%
Interest burden factor: 10.090712742980562
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CSR (quarterly period ending 2025-12-31)
ROE: -2.1211071865549322%
Net margin: -27.58289428258357%
Asset turnover: 0.03311369702018479
Equity multiplier (leverage): 2.322282821986749
EBIT margin: 5.547800243166569%
Interest burden factor: -5.811147186147186
ROE archetype: Low Return
DuPont ROE decomposition for CSR (quarterly period ending 2026-03-31)
ROE: -1.5443160456266443%
Net margin: -19.720604281608754%
Asset turnover: 0.034123342544732184
Equity multiplier (leverage): 2.2949033478634475
EBIT margin: 6.58685395503235%
Interest burden factor: -3.493467102193187
ROE archetype: Low Return
DuPont ROE decomposition for CTA.V (quarterly period ending 2024-12-31)
ROE: -0.7780320366132725%
Net margin: -850%
Asset turnover: 0.0004967709885742673
Equity multiplier (leverage): 1.8425629290617853
EBIT margin: -1950%
ROE archetype: Low Return
DuPont ROE decomposition for CTA.V (quarterly period ending 2025-03-31)
ROE: -0.4904966278356837%
Net margin: -1066.6666666666665%
Asset turnover: 0.000248714972641353
Equity multiplier (leverage): 1.8488657265481299
EBIT margin: -4066.666666666667%
ROE archetype: Low Return
DuPont ROE decomposition for CTA.V (quarterly period ending 2025-06-30)
ROE: -0.8222925773608565%
Net margin: -2600%
Asset turnover: 0.0001689861892196265
Equity multiplier (leverage): 1.8715516183217755
EBIT margin: -8350%
ROE archetype: Low Return
DuPont ROE decomposition for CTA.V (quarterly period ending 2025-09-30)
ROE: 0.477701185367069%
Net margin: 1550%
Asset turnover: 0.00016423678148655868
Equity multiplier (leverage): 1.876524310513644
EBIT margin: -6049.999999999999%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CTA.V (quarterly period ending 2025-12-31)
ROE: 2.7230603466165952%
Net margin: 5899.999999999999%
Asset turnover: 0.0002492144813335664
Equity multiplier (leverage): 1.8519616095308773
EBIT margin: -4233.333333333334%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CTA.V (quarterly period ending 2026-03-31)
ROE: -2.6711212893290646%
Net margin: -8850%
Asset turnover: 0.00016307150536722483
Equity multiplier (leverage): 1.8508544085232665
EBIT margin: -16049.999999999996%
ROE archetype: Low Return
DuPont ROE decomposition for CTO.AX (annual period ending 2021-06-30)
ROE: -1.3862336766811403%
Equity multiplier (leverage): 1.0922428502988775
ROE archetype: Low Return
DuPont ROE decomposition for CTO.AX (annual period ending 2022-06-30)
ROE: -1.7842235854307418%
Equity multiplier (leverage): 1.1015877129739255
ROE archetype: Low Return
DuPont ROE decomposition for CTO.AX (annual period ending 2023-06-30)
ROE: -2.2879638825412543%
Equity multiplier (leverage): 1.12802997913578
ROE archetype: Low Return
DuPont ROE decomposition for CTO.AX (annual period ending 2024-06-30)
ROE: -2.373771794884591%
Net margin: -5023.558695652174%
Asset turnover: 0.00040705309728374973
Equity multiplier (leverage): 1.160850841792088
EBIT margin: -4606.621739130434%
ROE archetype: Low Return
DuPont ROE decomposition for CUE.AX (annual period ending 2022-06-30)
ROE: 33.51829446368225%
Net margin: 36.15742928508743%
Asset turnover: 0.415679048144649
Equity multiplier (leverage): 2.2301097250615376
EBIT margin: 47.242287180179574%
Interest burden factor: 1.0135276745736876
Tax burden factor: 0.7551461603534166
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CUE.AX (annual period ending 2023-06-30)
ROE: 26.659389387880612%
Net margin: 29.475825985854087%
Asset turnover: 0.45004084828630414
Equity multiplier (leverage): 2.0097048447409773
EBIT margin: 40.86231954267997%
Interest burden factor: 0.9428083653435767
Tax burden factor: 0.7651023590362658
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CUE.AX (annual period ending 2024-06-30)
ROE: 22.053003029106247%
Net margin: 28.57286695261685%
Asset turnover: 0.4308703821227016
Equity multiplier (leverage): 1.7912956708864594
EBIT margin: 50.925310618417605%
Interest burden factor: 1.0013049151805133
Tax burden factor: 0.5603427849301004
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CUE.AX (annual period ending 2025-06-30)
ROE: 10.165185879983852%
Net margin: 11.516930763479877%
Asset turnover: 0.4788150469162961
Equity multiplier (leverage): 1.8433626293260783
EBIT margin: 38.17946426943345%
Interest burden factor: 0.9388671315311873
Tax burden factor: 0.32129412961644116
ROE archetype: Standard Business
DuPont ROE decomposition for CURI (annual period ending 2022-12-31)
ROE: -43.287198408515124%
Net margin: -65.24223825327063%
Asset turnover: 0.5064011472101639
Equity multiplier (leverage): 1.3101950249094587
EBIT margin: -66.2211857565701%
ROE archetype: Low Return
DuPont ROE decomposition for CURI (annual period ending 2023-12-31)
ROE: -51.39589640094181%
Net margin: -85.94983212923412%
Asset turnover: 0.4459521429831266
Equity multiplier (leverage): 1.340896190716448
EBIT margin: -44.82588901193552%
ROE archetype: Low Return
DuPont ROE decomposition for CURI (annual period ending 2024-12-31)
ROE: -19.83386209327632%
Net margin: -25.308014237102515%
Asset turnover: 0.5462917459028653
Equity multiplier (leverage): 1.434579367633761
EBIT margin: -26.074627449446552%
ROE archetype: Low Return
DuPont ROE decomposition for CURI (annual period ending 2025-12-31)
ROE: -12.940051341420448%
Net margin: -8.968991598984063%
Asset turnover: 0.8851420207148283
Equity multiplier (leverage): 1.6299692958171843
EBIT margin: -10.192860531971307%
ROE archetype: Low Return
DuPont ROE decomposition for CURR (quarterly period ending 2024-12-31)
Net margin: -249.1305712500663%
Asset turnover: 0.10570223996781963
EBIT margin: -78.4035729530175%
ROE archetype: Standard Business
DuPont ROE decomposition for CURR (quarterly period ending 2025-03-31)
Net margin: -44.62560000334143%
Asset turnover: 0.09402196126128089
EBIT margin: -42.96977127798536%
ROE archetype: Standard Business
DuPont ROE decomposition for CURR (quarterly period ending 2025-06-30)
Net margin: -53.43299788515563%
Asset turnover: 0.0869719204698555
EBIT margin: -49.87468757980883%
ROE archetype: Standard Business
DuPont ROE decomposition for CURR (quarterly period ending 2025-09-30)
Net margin: 30.204389884889387%
Asset turnover: 0.11413829261063237
EBIT margin: 45.76230355914511%
Interest burden factor: 0.6536167766940653
Tax burden factor: 1.0098084466180237
ROE archetype: Standard Business
DuPont ROE decomposition for CURR (quarterly period ending 2025-12-31)
ROE: -55.71521665979393%
Net margin: -138.87847861626227%
Asset turnover: 0.08640719352381063
Equity multiplier (leverage): 4.642896194089101
EBIT margin: -46.54881064160403%
ROE archetype: Low Return
DuPont ROE decomposition for CURV (annual period ending 2023-01-31)
Net margin: 3.897778509234992%
Asset turnover: 2.443072161194392
EBIT margin: 7.889257722739072%
Interest burden factor: 0.7053579335793357
Tax burden factor: 0.7004408359141765
ROE archetype: Standard Business
DuPont ROE decomposition for CURV (annual period ending 2024-01-31)
Net margin: 1.008641905646537%
Asset turnover: 2.294229001673951
EBIT margin: 4.961000742222936%
Interest burden factor: 0.31558409743123117
Tax burden factor: 0.6442472969226504
ROE archetype: Standard Business
DuPont ROE decomposition for CURV (annual period ending 2025-01-31)
Net margin: 1.4784319090507976%
Asset turnover: 2.286618437353686
EBIT margin: 5.183118804570292%
Interest burden factor: 0.37762201090756536
Tax burden factor: 0.7553580521223904
ROE archetype: Standard Business
DuPont ROE decomposition for CURV (annual period ending 2026-01-31)
Net margin: -0.70333529315303%
Asset turnover: 2.2504801520284525
EBIT margin: 2.1400031197129863%
Interest burden factor: -0.4466872254929446
ROE archetype: Standard Business
DuPont ROE decomposition for CUZ (quarterly period ending 2025-03-31)
ROE: 0.4360694990544902%
Net margin: 8.426144897893963%
Asset turnover: 0.028895024563217967
Equity multiplier (leverage): 1.791033544459635
EBIT margin: 24.1079703429101%
Interest burden factor: 0.3495169762547847
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUZ (quarterly period ending 2025-06-30)
ROE: 0.3041638575397589%
Net margin: 6.104244402985075%
Asset turnover: 0.027109791392408666
Equity multiplier (leverage): 1.8380169753230522
EBIT margin: 23.038129664179106%
Interest burden factor: 0.26496267240288496
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUZ (quarterly period ending 2025-09-30)
ROE: 0.18366291390063372%
Net margin: 3.5348694860787835%
Asset turnover: 0.027665022461690798
Equity multiplier (leverage): 1.8780928516669848
EBIT margin: 21.552716992985026%
Interest burden factor: 0.16401038844565685
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUZ (quarterly period ending 2025-12-31)
ROE: -0.06928217263142761%
Net margin: -1.2849267156535993%
Asset turnover: 0.02867062534607436
Equity multiplier (leverage): 1.8806413199342698
EBIT margin: 22.007261776861125%
Interest burden factor: -0.05838648754587891
ROE archetype: Low Return
DuPont ROE decomposition for CUZ (quarterly period ending 2026-03-31)
ROE: -0.5342572714049677%
Net margin: -9.376342124366706%
Asset turnover: 0.02927014861239934
Equity multiplier (leverage): 1.94666880196326
EBIT margin: 22.909896658799205%
Interest burden factor: -0.40927038057002557
ROE archetype: Low Return
DuPont ROE decomposition for CVE (quarterly period ending 2025-03-31)
ROE: 2.858854461343895%
Net margin: 6.047166490672298%
Asset turnover: 0.25195104647037964
Equity multiplier (leverage): 1.8763936499484142
EBIT margin: 9.039070749736007%
Interest burden factor: 0.8800623052959501
Tax burden factor: 0.7601769911504426
ROE archetype: Low Return
DuPont ROE decomposition for CVE (quarterly period ending 2025-06-30)
ROE: 2.92423348596131%
Net margin: 6.908028249046187%
Asset turnover: 0.22431950959868385
Equity multiplier (leverage): 1.8870825308449888
EBIT margin: 5.6011039857131255%
Interest burden factor: 1.472463768115942
Tax burden factor: 0.8375984251968503
ROE archetype: Low Return
DuPont ROE decomposition for CVE (quarterly period ending 2025-09-30)
ROE: 4.416554194300108%
Net margin: 9.746115953012506%
Asset turnover: 0.23945653870743683
Equity multiplier (leverage): 1.8924538144677236
EBIT margin: 11.466464569912848%
Interest burden factor: 0.8572372769332453
Tax burden factor: 0.9915188897455667
ROE archetype: Low Return
DuPont ROE decomposition for CVE (quarterly period ending 2025-12-31)
ROE: 3.1332542936354937%
Net margin: 6.701104893098006%
Asset turnover: 0.2398427229173683
Equity multiplier (leverage): 1.9494974945622494
EBIT margin: 8.179078777442962%
Interest burden factor: 0.9070175438596491
Tax burden factor: 0.9032882011605416
ROE archetype: Low Return
DuPont ROE decomposition for CVE (quarterly period ending 2026-03-31)
ROE: 4.858209247673242%
Net margin: 11.769997750955845%
Asset turnover: 0.20648942786350732
Equity multiplier (leverage): 1.9989503882851858
EBIT margin: 17.684983881850215%
Interest burden factor: 0.8834251801610852
Tax burden factor: 0.753358925143954
ROE archetype: Low Return
DuPont ROE decomposition for CVRX (quarterly period ending 2025-03-31)
ROE: -19.84717416378316%
Net margin: -111.4836410754778%
Asset turnover: 0.09528586531264227
Equity multiplier (leverage): 1.8683535178777393
EBIT margin: -108.8192419825073%
ROE archetype: Low Return
DuPont ROE decomposition for CVRX (quarterly period ending 2025-06-30)
ROE: -23.152701619872108%
Net margin: -108.44065052616088%
Asset turnover: 0.10908156835358193
Equity multiplier (leverage): 1.9573035649755683
EBIT margin: -105.7914489660755%
ROE archetype: Low Return
DuPont ROE decomposition for CVRX (quarterly period ending 2025-09-30)
ROE: -24.285768200173603%
Net margin: -87.61061946902655%
Asset turnover: 0.12724729198879114
Equity multiplier (leverage): 2.1784447295920293
EBIT margin: -83.51259360108918%
ROE archetype: Low Return
DuPont ROE decomposition for CVRX (quarterly period ending 2025-12-31)
ROE: -27.315800315868984%
Net margin: -74.47578632051922%
Asset turnover: 0.14828867429517997
Equity multiplier (leverage): 2.473380027009087
EBIT margin: -69.79530703944083%
ROE archetype: Low Return
DuPont ROE decomposition for CVRX (quarterly period ending 2026-03-31)
ROE: -38.34407376558093%
Net margin: -88.83472137585483%
Asset turnover: 0.1444245606829583
Equity multiplier (leverage): 2.988645828766823
EBIT margin: -82.34139075089715%
ROE archetype: Low Return
DuPont ROE decomposition for CVX (quarterly period ending 2025-03-31)
ROE: 2.340085287846482%
Net margin: 7.6180560074618775%
Asset turnover: 0.17980319582522417
Equity multiplier (leverage): 1.708402185501066
EBIT margin: 9.320839027352985%
Interest burden factor: 1.2992785664417035
Tax burden factor: 0.6290524807451191
ROE archetype: Low Return
DuPont ROE decomposition for CVX (quarterly period ending 2025-06-30)
ROE: 1.6916774848825242%
Net margin: 5.667605633802817%
Asset turnover: 0.17497441923279386
Equity multiplier (leverage): 1.7058599977130404
EBIT margin: 9.142535211267605%
Interest burden factor: 1.0221838797140745
Tax burden factor: 0.6064625030142271
ROE archetype: Low Return
DuPont ROE decomposition for CVX (quarterly period ending 2025-09-30)
ROE: 2.1075780643881723%
Net margin: 7.500674707799622%
Asset turnover: 0.1668707703340083
Equity multiplier (leverage): 1.683848707044899
EBIT margin: 8.920675123004422%
Interest burden factor: 1.2599488014894111
Tax burden factor: 0.6673439231621722
ROE archetype: Low Return
DuPont ROE decomposition for CVX (quarterly period ending 2025-12-31)
ROE: 1.4673419706222148%
Net margin: 6.213554065564462%
Asset turnover: 0.14077197534868635
Equity multiplier (leverage): 1.677548378445288
EBIT margin: 8.78633673313386%
Interest burden factor: 1.1431767337807606
Tax burden factor: 0.6186127419004132
ROE archetype: Low Return
DuPont ROE decomposition for CVX (quarterly period ending 2026-03-31)
ROE: 1.2019489079982282%
Net margin: 4.821683909496173%
Asset turnover: 0.14552843413718342
Equity multiplier (leverage): 1.7129292066246098
EBIT margin: 6.7751703255109765%
Interest burden factor: 1.2247051520794539
Tax burden factor: 0.5810947795235681
ROE archetype: Low Return
DuPont ROE decomposition for CWV.V (annual period ending 2022-12-31)
ROE: -22.80588140723447%
Net margin: -17.877385472790763%
Asset turnover: 0.4845834729014611
Equity multiplier (leverage): 2.6325356369949233
EBIT margin: -3.964523062823881%
ROE archetype: Low Return
DuPont ROE decomposition for CWV.V (annual period ending 2023-12-31)
ROE: -37.82876467881205%
Net margin: -30.365249821528835%
Asset turnover: 0.3996038525470454
Equity multiplier (leverage): 3.1175658411902667
EBIT margin: -27.50712203452799%
ROE archetype: Low Return
DuPont ROE decomposition for CWV.V (annual period ending 2024-12-31)
ROE: -65.57674386326549%
Net margin: -24.834446904645755%
Asset turnover: 0.25256670627027084
Equity multiplier (leverage): 10.454884894569675
EBIT margin: -35.36162904560813%
ROE archetype: Low Return
DuPont ROE decomposition for CWV.V (annual period ending 2025-12-31)
ROE: -78.05077826941107%
Net margin: -4.642129868135457%
Asset turnover: 0.40641752098424366
Equity multiplier (leverage): 41.37019132114934
EBIT margin: -24.50530977390005%
ROE archetype: Low Return
DuPont ROE decomposition for CXE (quarterly period ending 2024-11-30)
Equity multiplier (leverage): 1.6005072393140585
ROE archetype: Standard Business
DuPont ROE decomposition for CXE (quarterly period ending 2025-05-31)
Equity multiplier (leverage): 1.6319801712854134
ROE archetype: Standard Business
DuPont ROE decomposition for CXE (quarterly period ending 2025-11-30)
Equity multiplier (leverage): 1.652803700990676
ROE archetype: Standard Business
DuPont ROE decomposition for CXM (quarterly period ending 2025-01-31)
ROE: 16.12235995314208%
Net margin: 48.720987069157054%
Asset turnover: 0.1710345980700879
Equity multiplier (leverage): 1.9347665191328343
EBIT margin: 5.163943734293149%
Interest burden factor: 1.4697389807821015
Tax burden factor: 6.419398907103825
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CXM (quarterly period ending 2025-04-30)
ROE: -0.2505122480199068%
Net margin: -0.7630170316301703%
Asset turnover: 0.17314689639454237
Equity multiplier (leverage): 1.8961820048169287
EBIT margin: 7.08418491484185%
Interest burden factor: 0.3554746531116912
Tax burden factor: -0.3029951690821256
ROE archetype: Low Return
DuPont ROE decomposition for CXM (quarterly period ending 2025-07-31)
ROE: 2.1323367215766615%
Net margin: 5.949349179400113%
Asset turnover: 0.18635792163985127
Equity multiplier (leverage): 1.9232620779591771
EBIT margin: 7.2099603848330505%
Interest burden factor: 1.5529173207744635
Tax burden factor: 0.531359251927046
ROE archetype: Low Return
DuPont ROE decomposition for CXM (quarterly period ending 2025-10-31)
ROE: 0.527270449432694%
Net margin: 1.3256157905307941%
Asset turnover: 0.20473625725583433
Equity multiplier (leverage): 1.9427682787996972
EBIT margin: 5.51472602114412%
Interest burden factor: 1.4331595066633558
Tax burden factor: 0.16772554002541296
ROE archetype: Low Return
DuPont ROE decomposition for CXM (quarterly period ending 2026-01-31)
ROE: 1.556232228641347%
Net margin: 4.059077391745848%
Asset turnover: 0.19530489829345493
Equity multiplier (leverage): 1.963061644454641
EBIT margin: 6.843856531515195%
Interest burden factor: 1.3617937338544082
Tax burden factor: 0.43552701979668274
ROE archetype: Low Return
DuPont ROE decomposition for CXM (quarterly period ending 2026-04-30)
ROE: 0.7734693179095794%
Net margin: 1.9049658509470153%
Asset turnover: 0.19363732449662713
Equity multiplier (leverage): 2.0968473864192405
EBIT margin: 4.535741460458632%
Interest burden factor: 1.637167252636866
Tax burden factor: 0.2565345441158424
ROE archetype: Low Return
DuPont ROE decomposition for CYAB (annual period ending 2022-12-31)
Net margin: -759.5238095238095%
Asset turnover: 0.35388026607538803
EBIT margin: -711.9047619047618%
ROE archetype: Standard Business
DuPont ROE decomposition for CYAB (annual period ending 2023-12-31)
Net margin: -340.79084287200834%
Asset turnover: 1.2408005164622338
EBIT margin: -309.105098855359%
ROE archetype: Standard Business
DuPont ROE decomposition for CYAB (annual period ending 2024-12-31)
Net margin: -375.6919374247894%
Asset turnover: 2.978494623655914
EBIT margin: -221.37184115523465%
ROE archetype: Standard Business
DuPont ROE decomposition for CYAB (annual period ending 2025-12-31)
Net margin: -224.6188890835816%
Asset turnover: 3.352129221732746
EBIT margin: -209.7424215875241%
ROE archetype: Standard Business
DuPont ROE decomposition for CYC.AX (annual period ending 2022-12-31)
ROE: -18.095589601772033%
Net margin: -28.474838726571406%
Asset turnover: 0.4686675190990396
Equity multiplier (leverage): 1.355959159867322
EBIT margin: -32.878895491441696%
ROE archetype: Low Return
DuPont ROE decomposition for CYC.AX (annual period ending 2023-12-31)
ROE: -13.764696889187466%
Net margin: -17.84705787974049%
Asset turnover: 0.5557603948372581
Equity multiplier (leverage): 1.3877538018011226
EBIT margin: -38.060271633483985%
ROE archetype: Low Return
DuPont ROE decomposition for CYC.AX (annual period ending 2024-12-31)
ROE: -33.70880595582586%
Net margin: -47.865007632038505%
Asset turnover: 0.48905738014471944
Equity multiplier (leverage): 1.4400097066378799
EBIT margin: -52.6775857508588%
ROE archetype: Low Return
DuPont ROE decomposition for CYC.AX (annual period ending 2025-12-31)
ROE: -51.66791353074779%
Net margin: -103.15994659616447%
Asset turnover: 0.3222571035350582
Equity multiplier (leverage): 1.5542014726662206
EBIT margin: -202.57792841954628%
ROE archetype: Low Return
DuPont ROE decomposition for CYN (annual period ending 2022-12-31)
ROE: -79.76153193484555%
Net margin: -7342.179007633588%
Asset turnover: 0.010272490755934558
Equity multiplier (leverage): 1.0575301522415628
EBIT margin: -7404.857633587787%
ROE archetype: Low Return
DuPont ROE decomposition for CYN (annual period ending 2023-12-31)
ROE: -131.2773942617895%
Net margin: -1531.6571287375355%
Asset turnover: 0.07729009178593137
Equity multiplier (leverage): 1.1089311120316467
EBIT margin: -1567.5602977740803%
ROE archetype: Low Return
DuPont ROE decomposition for CYN (annual period ending 2024-12-31)
ROE: -695.4131586740046%
Net margin: -9055.18555541672%
Asset turnover: 0.017071599993554176
Equity multiplier (leverage): 4.498537279578875
EBIT margin: -6200.955891540672%
ROE archetype: Low Return
DuPont ROE decomposition for CYN (annual period ending 2025-12-31)
ROE: -124.48399731717272%
Net margin: -10717.737560280579%
Asset turnover: 0.005464252609691173
Equity multiplier (leverage): 2.1255906874386876
EBIT margin: -11731.07600832968%
ROE archetype: Low Return
DuPont ROE decomposition for CZR (annual period ending 2022-12-31)
ROE: -23.96694214876033%
Net margin: -8.30791978560207%
Asset turnover: 0.32275479464312345
Equity multiplier (leverage): 8.938149826712877
EBIT margin: 17.19804084650217%
Interest burden factor: -0.30360021493820527
ROE archetype: Low Return
DuPont ROE decomposition for CZR (annual period ending 2023-12-31)
ROE: 19.54904969897297%
Net margin: 7.182512144344205%
Asset turnover: 0.34466984587326027
Equity multiplier (leverage): 7.896706410105065
EBIT margin: 22.154753643303263%
Interest burden factor: -0.023492560689115115
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CZR (annual period ending 2024-12-31)
ROE: -4.639401934916447%
Net margin: -1.87638950644731%
Asset turnover: 0.34098489902359147
Equity multiplier (leverage): 7.251099384344767
EBIT margin: 20.23121387283237%
Interest burden factor: -0.05450549450549451
ROE archetype: Low Return
DuPont ROE decomposition for CZR (annual period ending 2025-12-31)
ROE: -10.84098238650459%
Net margin: -3.8046317255789655%
Asset turnover: 0.3576577558423765
Equity multiplier (leverage): 7.966881667080129
EBIT margin: 18.09158976144872%
Interest burden factor: -0.21559191530317612
ROE archetype: Low Return
DuPont ROE decomposition for DAKT (quarterly period ending 2025-01-31)
ROE: -6.300612212669534%
Net margin: -11.475047991063963%
Asset turnover: 0.2852337853616099
Equity multiplier (leverage): 1.9249846671392004
EBIT margin: -2.4266422307985582%
ROE archetype: Low Return
DuPont ROE decomposition for DAKT (quarterly period ending 2025-04-30)
ROE: -3.4636600504940995%
Net margin: -5.4621532184687425%
Asset turnover: 0.33601350667154795
Equity multiplier (leverage): 1.8871857440529785
EBIT margin: -9.979658188013978%
ROE archetype: Low Return
DuPont ROE decomposition for DAKT (quarterly period ending 2025-07-31)
ROE: 5.970831022219322%
Net margin: 7.521509599400837%
Asset turnover: 0.41769299073041716
Equity multiplier (leverage): 1.900520589760043
EBIT margin: 10.627842829220175%
Interest burden factor: 0.9549243726366449
Tax burden factor: 0.741124060657877
ROE archetype: Standard Business
DuPont ROE decomposition for DAKT (quarterly period ending 2025-10-31)
ROE: 6.057151569121382%
Net margin: 7.625200106432631%
Asset turnover: 0.419115435769229
Equity multiplier (leverage): 1.8953243405255007
EBIT margin: 9.405765682455627%
Interest burden factor: 1.0138663451282288
Tax burden factor: 0.7996066233647425
ROE archetype: Standard Business
DuPont ROE decomposition for DAKT (quarterly period ending 2026-01-31)
ROE: 1.0182868761089938%
Net margin: 1.6550192169174853%
Asset turnover: 0.33225426345259734
Equity multiplier (leverage): 1.8518105039166832
EBIT margin: 1.0567930016330256%
Interest burden factor: 1.8272632674297606
Tax burden factor: 0.8570615034168565
ROE archetype: Low Return
DuPont ROE decomposition for DAKT (quarterly period ending 2026-04-30)
ROE: 2.8310218087924843%
Net margin: 4.033843056421073%
Asset turnover: 0.37901939338001506
Equity multiplier (leverage): 1.85166656854252
EBIT margin: 4.957096975216912%
Interest burden factor: 1.0382941688424716
Tax burden factor: 0.7837384744341995
ROE archetype: Low Return
DuPont ROE decomposition for DAVANGERE.NS (annual period ending 2022-03-31)
ROE: 2.2972871861760744%
Net margin: 5.161667298232795%
Asset turnover: 0.19182536352529192
Equity multiplier (leverage): 2.3201670357225908
EBIT margin: 23.19210787694729%
Interest burden factor: 0.26119938091413125
Tax burden factor: 0.8520746452251657
ROE archetype: Low Return
DuPont ROE decomposition for DAVANGERE.NS (annual period ending 2023-03-31)
ROE: 4.5608495187245826%
Net margin: 4.816731035487867%
Asset turnover: 0.45073957371901974
Equity multiplier (leverage): 2.100717520287466
EBIT margin: 16.115280915251766%
Interest burden factor: 0.3997286909337554
Tax burden factor: 0.7477375565610859
ROE archetype: Low Return
DuPont ROE decomposition for DAVANGERE.NS (annual period ending 2024-03-31)
ROE: 3.725736107624638%
Net margin: 5.80674091191641%
Asset turnover: 0.327299538635423
Equity multiplier (leverage): 1.9603528514597324
EBIT margin: 18.484884432697648%
Interest burden factor: 0.37099672447607024
Tax burden factor: 0.8467313387395865
ROE archetype: Low Return
DuPont ROE decomposition for DAVANGERE.NS (annual period ending 2025-03-31)
ROE: 3.1312864152391975%
Net margin: 5.087371090023364%
Asset turnover: 0.29821442719835356
Equity multiplier (leverage): 2.0639573845758568
EBIT margin: 18.271807421251594%
Interest burden factor: 0.3273534495706652
Tax burden factor: 0.8505404774865852
ROE archetype: Low Return
DuPont ROE decomposition for DAVANGERE.NS (annual period ending 2026-03-31)
ROE: 1.910086775216099%
Net margin: 3.562636583929647%
Asset turnover: 0.2879401056810303
Equity multiplier (leverage): 1.8619988769778175
EBIT margin: 15.039246546714322%
Interest burden factor: 0.3060212310914073
Tax burden factor: 0.7740943298359284
ROE archetype: Low Return
DuPont ROE decomposition for DB (quarterly period ending 2025-03-31)
ROE: 2.466683830470652%
Net margin: 23.54868913857678%
Asset turnover: 0.00603029120293158
Equity multiplier (leverage): 17.370345850650356
Tax burden factor: 0.7091998590059923
ROE archetype: Low Return
DuPont ROE decomposition for DB (quarterly period ending 2025-06-30)
ROE: 2.262212854115465%
Net margin: 22.158291778544946%
Asset turnover: 0.005778622621144951
Equity multiplier (leverage): 17.667408696017386
Tax burden factor: 0.7158199091284594
ROE archetype: Low Return
DuPont ROE decomposition for DB (quarterly period ending 2025-09-30)
ROE: 2.3211893064505866%
Net margin: 22.66949152542373%
Asset turnover: 0.005753876911206435
Equity multiplier (leverage): 17.795418873221486
Tax burden factor: 0.7439672801635991
ROE archetype: Low Return
DuPont ROE decomposition for DB (quarterly period ending 2025-12-31)
ROE: 1.9788661122321334%
Net margin: 20.412397873168203%
Asset turnover: 0.005456578942247373
Equity multiplier (leverage): 17.766502599304754
Tax burden factor: 0.7765170202269365
ROE archetype: Low Return
DuPont ROE decomposition for DB (quarterly period ending 2026-03-31)
ROE: 2.688312829474349%
Net margin: 25.089440276976337%
Asset turnover: 0.005870874073411829
Equity multiplier (leverage): 18.250974857095645
Tax burden factor: 0.7148964156527459
ROE archetype: Low Return
DuPont ROE decomposition for DBCORP.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.3950250138577378
ROE archetype: Standard Business
DuPont ROE decomposition for DBCORP.NS (quarterly period ending 2024-12-31)
Net margin: 18.394063359231186%
EBIT margin: 24.59709983459192%
Interest burden factor: 1.012525779065501
Tax burden factor: 0.7385632349082185
ROE archetype: Standard Business
DuPont ROE decomposition for DBCORP.NS (quarterly period ending 2025-03-31)
ROE: 2.3524324440952302%
Net margin: 9.555981207215465%
Asset turnover: 0.17928692088102036
Equity multiplier (leverage): 1.3730718540587483
EBIT margin: 12.106847899323846%
Interest burden factor: 1.0676128137065637
Tax burden factor: 0.7393165411728143
ROE archetype: Low Return
DuPont ROE decomposition for DBCORP.NS (quarterly period ending 2025-06-30)
Net margin: 14.450442398784519%
EBIT margin: 15.432835820895525%
Interest burden factor: 1.2463313218823475
Tax burden factor: 0.7512801211817074
ROE archetype: Standard Business
DuPont ROE decomposition for DBCORP.NS (quarterly period ending 2025-12-31)
Net margin: 15.779569448345365%
EBIT margin: 19.04654121301237%
Interest burden factor: 1.1168602482586332
Tax burden factor: 0.7417886684012271
ROE archetype: Standard Business
DuPont ROE decomposition for DBCORP.NS (quarterly period ending 2026-03-31)
ROE: 2.5605997350138296%
Net margin: 10.789897829771805%
Asset turnover: 0.18031467341386928
Equity multiplier (leverage): 1.3161133495223578
EBIT margin: 14.489296328360437%
Interest burden factor: 1.0202358857690235
Tax burden factor: 0.7299102165365883
ROE archetype: Low Return
DuPont ROE decomposition for DBCORP.NS (quarterly period ending 2026-06-30)
Net margin: 16.683533778669258%
EBIT margin: 18.552884607421415%
Interest burden factor: 1.1981769647623894
Tax burden factor: 0.7505085351951061
ROE archetype: Standard Business
DuPont ROE decomposition for DBG.V (annual period ending 2022-02-28)
ROE: -19.029777878006517%
Asset turnover: 0
Equity multiplier (leverage): 1.045167920917936
ROE archetype: Low Return
DuPont ROE decomposition for DBG.V (annual period ending 2023-02-28)
ROE: -8.682730217161676%
Asset turnover: 0
Equity multiplier (leverage): 1.054415913648103
ROE archetype: Low Return
DuPont ROE decomposition for DBG.V (annual period ending 2024-02-29)
ROE: -8.683935594599523%
Asset turnover: 0
Equity multiplier (leverage): 1.0411844757357376
ROE archetype: Low Return
DuPont ROE decomposition for DBG.V (annual period ending 2025-02-28)
ROE: -7.873026248595651%
Asset turnover: 0
Equity multiplier (leverage): 1.0415776901606089
ROE archetype: Low Return
DuPont ROE decomposition for DBG.V (annual period ending 2026-02-28)
ROE: -11.474400554402646%
Asset turnover: 0
Equity multiplier (leverage): 1.0301398462511835
ROE archetype: Low Return
DuPont ROE decomposition for DBSTOCKBRO.NS (annual period ending 2023-03-31)
ROE: 11.144824770221453%
Net margin: 68.0490018371606%
Asset turnover: 0.08923170353798972
Equity multiplier (leverage): 1.8354066503810362
EBIT margin: -112.91947886592826%
Tax burden factor: 0.7327527632330211
ROE archetype: Standard Business
DuPont ROE decomposition for DBSTOCKBRO.NS (annual period ending 2024-03-31)
ROE: 14.546454622764829%
Net margin: 69.33749540161152%
Asset turnover: 0.11043305244699704
Equity multiplier (leverage): 1.8997214652032823
EBIT margin: -162.29276540367889%
Tax burden factor: 0.7740839379087867
ROE archetype: Standard Business
DuPont ROE decomposition for DBSTOCKBRO.NS (annual period ending 2025-03-31)
ROE: 8.265940701606533%
Net margin: 37.020168744522834%
Asset turnover: 0.12838744495196616
Equity multiplier (leverage): 1.7391271513577706
EBIT margin: -111.14174411984827%
Tax burden factor: 0.8145989922022351
ROE archetype: Standard Business
DuPont ROE decomposition for DBSTOCKBRO.NS (annual period ending 2026-03-31)
ROE: 4.013905001846687%
Net margin: 24.573435403677692%
Asset turnover: 0.10653254159353193
Equity multiplier (leverage): 1.5332710143670227
EBIT margin: -74.47952016415438%
Tax burden factor: 0.7139876175189176
ROE archetype: Low Return
DuPont ROE decomposition for DCBO (quarterly period ending 2025-03-31)
ROE: 2.811206682814259%
Net margin: 2.5726054174811503%
Asset turnover: 0.2898524330586373
Equity multiplier (leverage): 3.770011252455515
EBIT margin: 3.1956855626919847%
Interest burden factor: 1.2872747132714364
Tax burden factor: 0.6253712346202801
ROE archetype: Low Return
DuPont ROE decomposition for DCBO (quarterly period ending 2025-06-30)
ROE: 7.244720122887563%
Net margin: 5.064875189356517%
Asset turnover: 0.33682830135028974
Equity multiplier (leverage): 4.2466286912940845
EBIT margin: 8.367911479944674%
Interest burden factor: 0.921487603305785
Tax burden factor: 0.6568439034806749
ROE archetype: Standard Business
DuPont ROE decomposition for DCBO (quarterly period ending 2025-09-30)
ROE: 15.191352397253906%
Net margin: 9.91366719678037%
Asset turnover: 0.35521022057208734
Equity multiplier (leverage): 4.313965319377468
EBIT margin: 13.216059199636494%
Interest burden factor: 1.0125245579567779
Tax burden factor: 0.7408440455978657
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DCBO (quarterly period ending 2025-12-31)
ROE: 45.253883368196085%
Net margin: 42.59879118612878%
Asset turnover: 0.3340739624326578
Equity multiplier (leverage): 3.1799182086355104
EBIT margin: 14.946777289528374%
Interest burden factor: 0.9720866058161749
Tax burden factor: 2.931870291516541
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DCBO (quarterly period ending 2026-03-31)
ROE: -4.343008013211341%
Net margin: -2.4672355989027737%
Asset turnover: 0.28332492623772265
Equity multiplier (leverage): 6.2129123048303985
EBIT margin: -0.05943309966473636%
ROE archetype: Low Return
DuPont ROE decomposition for DCM.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 5.3322475570032575
ROE archetype: Standard Business
DuPont ROE decomposition for DCM.NS (quarterly period ending 2024-12-31)
Net margin: 118.56978085351788%
EBIT margin: 4.2099192618223755%
Interest burden factor: 29.06849315068493
Tax burden factor: 0.9688972667295006
ROE archetype: Standard Business
DuPont ROE decomposition for DCM.NS (quarterly period ending 2025-03-31)
ROE: 2.1900650262924297%
Net margin: 5.652435357787132%
Asset turnover: 0.13292430268694128
Equity multiplier (leverage): 2.9148553974618543
EBIT margin: -7.215874924834637%
Tax burden factor: 0.5529411764705883
ROE archetype: Low Return
DuPont ROE decomposition for DCM.NS (quarterly period ending 2025-06-30)
Net margin: 18.39863713798978%
EBIT margin: 1.7035775127768313%
Interest burden factor: 12.933333333333335
Tax burden factor: 0.8350515463917525
ROE archetype: Standard Business
DuPont ROE decomposition for DCM.NS (quarterly period ending 2025-09-30)
ROE: 3.044939101217976%
Net margin: 8.22928490351873%
Asset turnover: 0.1349054436873134
Equity multiplier (leverage): 2.7427551448971017
EBIT margin: -6.469920544835414%
Tax burden factor: 0.8529411764705883
ROE archetype: Low Return
DuPont ROE decomposition for DCM.NS (quarterly period ending 2025-12-31)
Net margin: -1.6968325791855206%
EBIT margin: -8.31447963800905%
Tax burden factor: -0.9375
ROE archetype: Standard Business
DuPont ROE decomposition for DCM.NS (quarterly period ending 2026-03-31)
ROE: -3.237564322469982%
Net margin: -8.002119766825649%
Asset turnover: 0.14597354374564864
Equity multiplier (leverage): 2.7716552315608913
EBIT margin: -0.582935877053524%
ROE archetype: Low Return
DuPont ROE decomposition for DD (annual period ending 2022-12-31)
ROE: 21.90102528037902%
Net margin: 45.455942229392335%
Asset turnover: 0.3147624229234675
Equity multiplier (leverage): 1.5307028907724767
EBIT margin: 15.533533072136438%
Interest burden factor: 0.7161226508407518
Tax burden factor: 4.086325966850829
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for DD (annual period ending 2023-12-31)
ROE: 1.7857833094971205%
Net margin: 6.9851829452676135%
Asset turnover: 0.16554244309009222
Equity multiplier (leverage): 1.544335356190329
EBIT margin: 12.428182642878742%
Interest burden factor: -0.33941605839416056
ROE archetype: Low Return
DuPont ROE decomposition for DD (annual period ending 2024-12-31)
ROE: 3.0421699163197164%
Net margin: 10.983777347819617%
Asset turnover: 0.1787253285098686
Equity multiplier (leverage): 1.549692897481347
EBIT margin: 11.11772585206132%
Interest burden factor: 0.1566265060240964
Tax burden factor: 6.3076923076923075
ROE archetype: Low Return
DuPont ROE decomposition for DD (annual period ending 2025-12-31)
ROE: -3.8948701709943%
Net margin: -10.775295663600525%
Asset turnover: 0.23531634914363264
Equity multiplier (leverage): 1.536072408697488
EBIT margin: 12.556577602569718%
Interest burden factor: 0.23255813953488372
Tax burden factor: -3.69
ROE archetype: Low Return
DuPont ROE decomposition for DEAL.V (annual period ending 2022-12-31)
Net margin: -1756.5580608617115%
Asset turnover: 0.11660811372683424
EBIT margin: -1715.5191621987065%
ROE archetype: Standard Business
DuPont ROE decomposition for DEAL.V (annual period ending 2023-12-31)
Net margin: -1123.035129340835%
Asset turnover: 0.21813036331763547
EBIT margin: -1051.2910277617561%
ROE archetype: Standard Business
DuPont ROE decomposition for DEAL.V (annual period ending 2024-12-31)
Net margin: -3009.445730920639%
Asset turnover: 0.16833378553227063
EBIT margin: -2389.086804062324%
ROE archetype: Standard Business
DuPont ROE decomposition for DEAL.V (annual period ending 2025-12-31)
Net margin: -26876.023698421854%
Asset turnover: 0.040587990800003436
EBIT margin: -16103.714675195302%
ROE archetype: Standard Business
DuPont ROE decomposition for DEC.V (annual period ending 2022-04-30)
ROE: -3.6605904679047243%
Asset turnover: 0
Equity multiplier (leverage): 1.0838216937256608
ROE archetype: Low Return
DuPont ROE decomposition for DEC.V (annual period ending 2023-04-30)
ROE: -8.036185767105634%
Asset turnover: 0
Equity multiplier (leverage): 1.077130581374635
ROE archetype: Low Return
DuPont ROE decomposition for DEC.V (annual period ending 2024-04-30)
ROE: -13.75214251798888%
Asset turnover: 0
Equity multiplier (leverage): 1.0909829065218353
ROE archetype: Low Return
DuPont ROE decomposition for DEC.V (annual period ending 2025-04-30)
ROE: -65.2618429720905%
Asset turnover: 0
Equity multiplier (leverage): 1.085991451490558
ROE archetype: Low Return
DuPont ROE decomposition for DEER.TO (annual period ending 2022-10-31)
ROE: 35.02971950680355%
Net margin: 13.905463905463906%
Asset turnover: 0.5696101299566811
Equity multiplier (leverage): 4.422557351279657
EBIT margin: 17.6007176007176%
Interest burden factor: 1.0111898958564147
Tax burden factor: 0.7813082064205106
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DEER.TO (annual period ending 2023-10-31)
ROE: 47.79235647785028%
Net margin: 16.873589164785553%
Asset turnover: 0.6165339828047977
Equity multiplier (leverage): 4.5940313479883885
EBIT margin: 24.218231310582922%
Interest burden factor: 0.8922623535055857
Tax burden factor: 0.7808587449112835
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DEER.TO (annual period ending 2024-10-31)
ROE: 31.576891567957983%
Net margin: 14.054396452749515%
Asset turnover: 0.4762226762641883
Equity multiplier (leverage): 4.717882324353137
EBIT margin: 22.619660319094184%
Interest burden factor: 0.8056357749190514
Tax burden factor: 0.771236150336737
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DEER.TO (annual period ending 2025-10-31)
ROE: 20.477859609086295%
Net margin: 11.25489757080488%
Asset turnover: 0.4172581554207298
Equity multiplier (leverage): 4.360518973406444
EBIT margin: 18.842494122915035%
Interest burden factor: 0.7434648288973383
Tax burden factor: 0.8034201694102605
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DELPHIFX.NS (annual period ending 2022-03-31)
ROE: 4.1254778596056285%
Net margin: 0.5264182755730888%
Asset turnover: 4.984668643267685
Equity multiplier (leverage): 1.5721971646128685
EBIT margin: 0.5552612918082512%
Interest burden factor: 1.6712148414123278
Tax burden factor: 0.5672849674138796
ROE archetype: Low Return
DuPont ROE decomposition for DELPHIFX.NS (annual period ending 2023-03-31)
ROE: 7.256576232978248%
Net margin: 0.5751629188543085%
Asset turnover: 8.260625269888
Equity multiplier (leverage): 1.5273126945600894
EBIT margin: 0.43165896762041545%
Interest burden factor: 1.9006997962618477
Tax burden factor: 0.7010299669105653
ROE archetype: Standard Business
DuPont ROE decomposition for DELPHIFX.NS (annual period ending 2024-03-31)
ROE: 7.039317539198746%
Net margin: 0.5294099198148877%
Asset turnover: 9.092039241850422
Equity multiplier (leverage): 1.4624370470858046
EBIT margin: 0.3465627733385373%
Interest burden factor: 2.2784313725490195
Tax burden factor: 0.6704620680524296
ROE archetype: Standard Business
DuPont ROE decomposition for DELPHIFX.NS (annual period ending 2025-03-31)
ROE: 0.8670360560232854%
Net margin: 0.1135221420437818%
Asset turnover: 5.400163908395295
Equity multiplier (leverage): 1.4143263705523523
EBIT margin: -0.0949405126555413%
Tax burden factor: 0.9903748733535968
ROE archetype: Low Return
DuPont ROE decomposition for DELPHIFX.NS (annual period ending 2026-03-31)
ROE: 2.3108371750760903%
Net margin: 0.31041295000228714%
Asset turnover: 2.83310355441072
Equity multiplier (leverage): 2.6276472666750776
EBIT margin: 0.04459997255386303%
Interest burden factor: 17.629807692307693
Tax burden factor: 0.39478229251886193
ROE archetype: Low Return
DuPont ROE decomposition for DEO (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.784441757355905
ROE archetype: Standard Business
DuPont ROE decomposition for DEO (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.76201611895061
ROE archetype: Standard Business
DuPont ROE decomposition for DEO (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.706480645968218
ROE archetype: Standard Business
DuPont ROE decomposition for DEVS (annual period ending 2022-07-31)
ROE: -12.347694965115434%
Asset turnover: 0
Equity multiplier (leverage): 5.3675336885788605
ROE archetype: Low Return
DuPont ROE decomposition for DEVS (annual period ending 2023-07-31)
ROE: -1554.4104025503252%
Asset turnover: 0
Equity multiplier (leverage): 6.878371025143659
ROE archetype: Low Return
DuPont ROE decomposition for DEVS (annual period ending 2024-07-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for DEVS (annual period ending 2025-07-31)
Net margin: -46783.09296735675%
Asset turnover: 0.004293935660716157
EBIT margin: -50617.20167480809%
ROE archetype: Standard Business
DuPont ROE decomposition for DEZ.DE (annual period ending 2021-12-31)
ROE: 6.492182188987083%
Net margin: 2.361961293513881%
Asset turnover: 1.2536237500968916
Equity multiplier (leverage): 2.192556084296397
EBIT margin: 1.8116614109936318%
Interest burden factor: 0.993174061433447
Tax burden factor: 1.3127147766323024
ROE archetype: Standard Business
DuPont ROE decomposition for DEZ.DE (annual period ending 2022-12-31)
ROE: 12.363967625521182%
Net margin: 4.238676602716558%
Asset turnover: 1.3261788115390958
Equity multiplier (leverage): 2.1995077257279005
EBIT margin: 5.50710850377887%
Interest burden factor: 0.8800383877159309
Tax burden factor: 0.8745910577971647
ROE archetype: Standard Business
DuPont ROE decomposition for DEZ.DE (annual period ending 2023-12-31)
ROE: 11.839191466850387%
Net margin: 3.9695618456766195%
Asset turnover: 1.374176305369993
Equity multiplier (leverage): 2.1703861816123915
EBIT margin: 6.3929817758821255%
Interest burden factor: 0.8203184230477635
Tax burden factor: 0.7569316081330869
ROE archetype: Standard Business
DuPont ROE decomposition for DEZ.DE (annual period ending 2024-12-31)
ROE: 6.314583274074856%
Net margin: 2.856040138942493%
Asset turnover: 1.0732227848051332
Equity multiplier (leverage): 2.06011044425572
EBIT margin: 1.9738655786513757%
Interest burden factor: 0.6899441340782122
Tax burden factor: 2.097165991902834
ROE archetype: Standard Business
DuPont ROE decomposition for DEZ.DE (annual period ending 2025-12-31)
ROE: 6.251643831081874%
Net margin: 2.647030042078481%
Asset turnover: 1.200901572242837
Equity multiplier (leverage): 1.9666539272892511
EBIT margin: 3.043350621391525%
Interest burden factor: 0.8794212218649519
Tax burden factor: 0.9890310786106032
ROE archetype: Standard Business
DuPont ROE decomposition for DFDV (quarterly period ending 2025-03-31)
ROE: -27.31943015461112%
Net margin: -271.0801393728223%
Asset turnover: 0.06902275562409198
Equity multiplier (leverage): 1.460096776798851
EBIT margin: -329.9651567944251%
ROE archetype: Low Return
DuPont ROE decomposition for DFDV (quarterly period ending 2025-06-30)
ROE: 37.42869793025267%
Net margin: 777.0392749244712%
Asset turnover: 0.035659121742943896
Equity multiplier (leverage): 1.3508001681768995
EBIT margin: -201.61127895266867%
Tax burden factor: 0.9277941441712259
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for DFDV (quarterly period ending 2025-09-30)
ROE: 34.64629255728672%
Net margin: 1211.372972972973%
Asset turnover: 0.01575315403689474
Equity multiplier (leverage): 1.8155631893190525
EBIT margin: -7.005405405405406%
Tax burden factor: 0.7575073349467962
ROE archetype: Balanced Compounder
DuPont ROE decomposition for DFDV (quarterly period ending 2025-12-31)
ROE: -84.22194044860304%
Net margin: -3218.9839572192514%
Asset turnover: 0.011400064011054608
Equity multiplier (leverage): 2.2950869368778513
EBIT margin: -52.361853832442065%
ROE archetype: Low Return
DuPont ROE decomposition for DFDV (quarterly period ending 2026-03-31)
ROE: -152.37312137408068%
Net margin: -3130.255255255255%
Asset turnover: 0.00991946023837982
Equity multiplier (leverage): 4.907276963135535
EBIT margin: -157.2822822822823%
ROE archetype: Low Return
DuPont ROE decomposition for DGICA (annual period ending 2022-12-31)
ROE: -0.4051764503164491%
Net margin: -0.23100183192214258%
Asset turnover: 0.37810453002853434
Equity multiplier (leverage): 4.638920082244695
ROE archetype: Low Return
DuPont ROE decomposition for DGICA (annual period ending 2023-12-31)
ROE: 0.9187849578493794%
Net margin: 0.4772266505153746%
Asset turnover: 0.41126889119316923
Equity multiplier (leverage): 4.681266086935855
Tax burden factor: 0.8740051300727011
ROE archetype: Low Return
DuPont ROE decomposition for DGICA (annual period ending 2024-12-31)
ROE: 9.919295254940467%
Net margin: 5.1396516216242025%
Asset turnover: 0.4300456237728239
Equity multiplier (leverage): 4.487790785777638
Tax burden factor: 0.8158986746837433
ROE archetype: Standard Business
DuPont ROE decomposition for DGICA (annual period ending 2025-12-31)
ROE: 13.377360862349851%
Net margin: 8.11243130241195%
Asset turnover: 0.4141793077741555
Equity multiplier (leverage): 3.9813559998745904
Tax burden factor: 0.8129759173142141
ROE archetype: Standard Business
DuPont ROE decomposition for DGL.AX (annual period ending 2021-06-30)
ROE: 24.15361215763076%
Net margin: 30.53205331303005%
Asset turnover: 0.556597655107745
Equity multiplier (leverage): 1.4212965570608767
EBIT margin: 7.147342325467816%
Interest burden factor: 4.483470698463225
Tax burden factor: 0.9527897861945974
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for DGL.AX (annual period ending 2022-06-30)
ROE: 10.895747588118246%
Net margin: 7.544302290340232%
Asset turnover: 0.9237798025523493
Equity multiplier (leverage): 1.56339777468748
EBIT margin: 12.864363192195693%
Interest burden factor: 0.8776145129680895
Tax burden factor: 0.6682315743136438
ROE archetype: Standard Business